Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults
- 26 July 2008
- Vol. 26 (38) , 4947-4954
- https://doi.org/10.1016/j.vaccine.2008.07.016
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Changing Epidemiology of Pneumococcal Meningitis after the Introduction of Pneumococcal Conjugate Vaccine in the United StatesClinical Infectious Diseases, 2008
- Population Snapshot of EmergentStreptococcus pneumoniaeSerotype 19A in the United States, 2005The Journal of Infectious Diseases, 2008
- Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes Among Alaska Native Children With High Levels of 7-Valent Pneumococcal Conjugate Vaccine CoverageJAMA, 2007
- World Health Organisation definition of “radiologically-confirmed pneumonia” may under-estimate the true public health value of conjugate pneumococcal vaccinesVaccine, 2006
- Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of SpainClinical Microbiology & Infection, 2005
- Post-PCV7 Changes in Colonizing Pneumococcal Serotypes in 16 Massachusetts Communities, 2001 and 2004Published by American Academy of Pediatrics (AAP) ,2005
- Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trialThe Lancet, 2005
- Impact of a Conjugate Vaccine on Community‐Wide Carriage of NonsusceptibleStreptococcus pneumoniaein AlaskaThe Journal of Infectious Diseases, 2004
- Population-Based Impact of Pneumococcal Conjugate Vaccine in Young ChildrenPublished by American Academy of Pediatrics (AAP) ,2004
- A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV InfectionNew England Journal of Medicine, 2003